Elekta retweeted
Real clinics are cutting toxicity in HALF with Adaptive RT & @Elekta 's Paul Barry & Brett Sloman will show you how. Unity Linac. Elekta ONE Planning. Real outcomes. Practical strategies. Q&A included. Mon. July 20 · 12:15 PM · Lunch session #AAPMCOMP2026 #AdaptiveRT #RadOnc
Elekta retweeted
SARO Rounds is honored to host the first SARO @Elekta Webinar by Dr. Douglas Kondziolka, Professor of Neurosurgery and RadiationOncology,New York University
Join us as we explore explore the Clinical and Technological Advantages of Leksell Gamma Knife.
🗓️ Wednesday, 26 NOV 2025
🕖 7:00 PM (KSA)
‼️Registration Required: us02web.zoom.us/meeting/regi…
@AbdulrazagAjlan
@DKondziolkaCNS
Elekta retweeted
At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!
Elekta retweeted
🇹🇷 Turkish RadOncs rising fast in the global MR-Linac community!
With 8 Elekta Unity systems, Türkiye is now among the leaders in MRLinac
At Acıbadem Maslak, we bring our 7 years of MR-Linac experience to life with Unity — for precision, innovation, and healing. #ElektaUnity
Elekta retweeted
8 years strong & still going! 🇸🇪 @Elekta is one of 170 enterprises that’s been part of the #CIIE journey since day one.
From debuting cutting-edge cancer care tech to building local production hubs in #China 🩹, this #Swedish medical giant’s commitment says it all.
“The open Chinese market fuels #innovation—we’re thrilled to deepen collaboration & serve more patients together,” says Laurent Leksell, #Elekta’s Founder & Board Chairman.
#GlobalInnovation
@FUSFoundation @Elekta @DrewMoghanaki @aapmHQ @ciieonline @SwissEmbChina @SwissMFAasia @swissinnova
@QiushiJournal
Elekta retweeted
This week the 2025 MR-Linac Consortium Meeting is being held in the United Kingdom. Several of our faculty are in attendance and presenting their work.
Follow the 🧵for more information on our department talks and presentations during the meeting:
Elekta retweeted
Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.
Elekta retweeted
Adam Mitchell sharing experience of treating prostate cancer in 2 fractions on the MR-linac within the DESTINATION 2 trial @royalmarsdenNHS @Elekta
Elekta retweeted
In under two years, @nyulangone has treated 400+ prostate cancer patients using MRI-guided linear accelerator (MR-Linac) technology—building one of the largest programs of its kind worldwide.
Learn more: bit.ly/3WVysP6
#ProstateCancer
Elekta retweeted
@dr_vesi presenting the DESTINATION2 trial, randomising between 2 fraction MRI-guided adaptive schedules, with 0mm PTV, at the MR-Linac consortium. Recruitment ongoing @Elekta @Xristodouleas
Elekta retweeted
The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.
Elekta retweeted
Looking forward to the 20th MR-Linac consortium hosted in London this year. Use of adaptive radiotherapy is the next frontier, need lots of collaboration to continue delivering high quality clinical data+trials to test the benefits @Xristodouleas @Elekta
Elekta retweeted
Leksell Gamma Knife Society Meeting. The Best Getting Better! @Elekta
Elekta retweeted
Replying to @Elekta
@Elekta Showcases Adaptive Innovations at ASTRO 2025
🔗 bit.ly/4hbLlhf
At the 67th annual meeting of the ASTRO in San Francisco, CA, Elekta spotlighted a trio of innovations that underscore its commitment to adaptive radiotherapy: the Evo CT-Linac, the Unity MR-Linac, and the Elekta ONE Planning system.
#RadOnc #RadOncNews #ASTRO25
Elekta retweeted
Explore the transformative potential of adaptive therapy in radiation oncology and its impact on cancer treatment. Join us for the next ASRT Live webcast, "Adaptive Therapy: Empowering RTTs and Enhancing Patient Outcomes," sponsored by @Elekta on Tuesday Oct. 21 at 11 a.m. Central time. bit.ly/4pULLga
Elekta retweeted
A special shoutout to the sponsors of the ROI 5k: Varian, A Siemens Healthineers Company, & Elekta. Thank you for your support & thank you to ROI Board President Gita Suneja, MD, MSHP, FASTRO, for helping to make today's Run for Research possible! #ASTRO25
@SiemensHealth @Elekta
Elekta retweeted
“This study represents an important contribution to our understanding of what is happening during prostate cancer radiation and how we can preserve a man’s quality of life after treatment.”
🔗 ow.ly/CLsr50X44Hx
@Elekta
#ASTRO25 #ASTRO2025 #RadOnc #ProstateCancer
Elekta retweeted
The 2025 ASRT Radiation Therapy Conference is in full swing in San Francisco. This year’s opening session, “Be an EPIC Leader: How to Navigate Change and Challenges With Confidence,” is sponsored by @Elekta. #ASRTRTC25



































